Interviews Archives - BaseLaunch

Podcast: Never underestimate the true value of IP with Philipp Marchand

If you invent something and want to sell it and make a profit there is no way around one major topic: protecting your intellectual property,…

Martyna Wroblewska10.10.2022

All Interviews Team interviews

Featured Interview: Stephan Emmerth, Director Business Development & Operations, BaseLaunch

Swiss biotech venture accelerator and incubator BaseLaunch was started in 2017 to help launch and grow the next generation of biotech companies. The accelerator has…

Sina Kohlbrenner16.12.2021

All Company interviews Interviews

“We master all the tricks of the trade” Interview with Thomas Fessard CEO of SpiroChem

Founded in 2011, the company moved to Basel in 2017. Today, SpiroChem has gained an excellent reputation for delivering best-in-class chemistry services and works with…

Sina Kohlbrenner01.11.2021

Neil Goldsmith Strategic mind at BaseLaunch

All Interviews Team interviews

Featured Interview: Neil Goldsmith, Director Strategy of BaseLaunch

You have been an entrepreneur all your life. How has this experience shaped you and what do you believe BaseLaunch can bring to the table…

Sina Kohlbrenner18.03.2021

All Interviews

Featured Interview: BaseLaunch Q&A session with Dr. Philipp Marchand

“IP rights are usually the true asset that a start-up company has.” Dr. Philipp Marchand talks with BaseLaunch and takes some questions from an audience…

Sina Kohlbrenner28.07.2020

All Company interviews Interviews

Featured Interview: Baselaunch chats with Silvio Bonaccio, ETH Zurich

Silvio Bonaccio is delighted by the strong entrepreneurial spirit that he encounters in his work as Head of ETH transfer. It took time, effort and…

Jérémie Meyer08.05.2020

Company interviews Interviews

“The first steps are slow and then suddenly things start rolling”

After more than 25 years in the pharma business, Andreas Katopodis founded the biotech company Anaveon together with Professor Onur Boyman. In 2019, the startup…

Jérémie Meyer06.12.2019

Interviews

Interview with Alex Mayweg, partner at Versant Ventures and president of Ridgeline, a Versant Ventures Discovery Engine

“We make no compromises in creating the highest potential company” Versant Ventures has a strong history in building successful companies such as Therachon, Black Diamond…

Jérémie Meyer30.07.2019

Interviews

Podcast Recap: Interview with George Yancopoulos, President and CSO of Regeneron Pharmaceuticals – “an overnight success story that took 25 years”

Regeneron Pharmaceuticals is one of the biggest biotech success stories. It’s the first biotech in history with 6 marketed drugs, all originated from its own…

Jérémie Meyer30.07.2019

Interviews

UCSF’s interview with Rob Nelson of ARCH Venture Partners

ARCH Venture Partners is behind companies such as Illumina, Alnylam, Unity Biotechnology, Receptos, Agios Pharmaceuticals, Grail, Bluebird, and many more. This interview is part of…

Jérémie Meyer24.05.2019

Interviews

Podcast: Never underestimate the true value of IP with Philipp Marchand

Featured Interview: Stephan Emmerth, Director Business Development & Operations, BaseLaunch

“We master all the tricks of the trade” Interview with Thomas Fessard CEO of SpiroChem

Featured Interview: Neil Goldsmith, Director Strategy of BaseLaunch

Featured Interview: BaseLaunch Q&A session with Dr. Philipp Marchand

Featured Interview: Baselaunch chats with Silvio Bonaccio, ETH Zurich

“The first steps are slow and then suddenly things start rolling”

Interview with Alex Mayweg, partner at Versant Ventures and president of Ridgeline, a Versant Ventures Discovery Engine

Podcast Recap: Interview with George Yancopoulos, President and CSO of Regeneron Pharmaceuticals – “an overnight success story that took 25 years”

UCSF’s interview with Rob Nelson of ARCH Venture Partners

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us